Nanox Imaging Ltd. (NASDAQ: NNOX) has entered into a distribution agreement with Costa Rica-based medical equipment distributor SOLME RC, S.A. to market and support the Nanox.ARC, a multi-source digital tomosynthesis system designed to expand access to 3D medical imaging. The deal, announced in a press release, represents Nanox's third Latin American market this year, following earlier agreements in Argentina and Peru. The move underscores the company's strategy to penetrate emerging markets and drive the global transition to preventive healthcare.
Under the agreement, SOLME will oversee marketing, distribution, installation, training, and ongoing technical support for the Nanox.ARC in Costa Rica. SOLME is a registered supplier to the Caja Costarricense de Seguro Social (CCSS), the country's principal purchaser and provider of hospital services. This relationship positions Nanox to leverage SOLME's established channels to reach key healthcare providers. Commercialization will proceed after applicable regulatory registration, including an initial six-month proof-of-concept device registration period before full registration. The phased approach allows for clinical validation and adaptation to local requirements.
The Nanox.ARC is a cost-effective, 3D multi-source digital tomosynthesis imaging system designed for ease of use and scalability. It is part of the broader Nanox ecosystem, which includes Nanox.AI, a suite of AI-based algorithms that augment interpretation of routine CT imaging to identify early signs of chronic disease; Nanox.CLOUD, a cloud-based platform for secure data management, storage, and advanced imaging analytics; Nanox.MARKETPLACE and USARAD Holdings, which provide access to remote radiology and cardiology experts and comprehensive teleradiology services; and Nanox Health IT, which combines healthcare IT expertise with technology partners to deliver RIS, PACS, AI, dictation, and secure infrastructure solutions. By integrating these components, Nanox aims to lower barriers to adoption, improve utilization, and advance preventive care worldwide.
The significance of this agreement lies in its potential to improve healthcare access in Costa Rica. The CCSS is the primary provider of hospital services, and by partnering with a registered supplier, Nanox can navigate the public procurement process more effectively. The proof-of-concept registration period will allow for real-world evaluation, which could lead to broader adoption. Moreover, this deal is part of Nanox's larger vision to expand medical imaging beyond traditional hospital settings, enabling earlier detection and improved patient outcomes. As the company continues to grow in Latin America, it demonstrates the scalability of its model and the increasing demand for affordable, advanced imaging solutions in emerging markets.
For investors, the announcement signals progress in Nanox's commercialization efforts and geographic expansion. The company's focus on preventive healthcare and integrated solutions could drive long-term value as healthcare systems worldwide seek cost-effective ways to enhance diagnostic capabilities. The latest news and updates relating to NNOX are available in the company's newsroom at http://ibn.fm/NNOX. To view the full press release, visit https://ibn.fm/C77lJ.
